Search

Author/Creator Pilla, Lorenzo

1. Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients. Issue 2 (15th February 2021)

Authors:
Huber, Veronica; Di Guardo, Lorenza; Lalli, Luca; Giardiello, Daniele; Cova, Agata; Squarcina, Paola; Frati, Paola; Di Giacomo, Anna Maria; Pilla, Lorenzo; Tazzari, Marcella; Camisaschi, Chiara; Arienti, Flavio; Castelli, Chiara; Rodolfo, Monica; Beretta, Valeria; Di Nicola, Massimo; Maio, Michel...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes. Issue 11 (13th December 2012)

Authors:
Russo, Vincenzo; Pilla, Lorenzo; Lunghi, Francesca; Crocchiolo, Roberto; Greco, Raffaella; Ciceri, Fabio; Maggioni, Daniela; Fontana, Raffaella; Mukenge, Sylvain; Rivoltini, Licia; Rigamonti, Gianluigi; Mercuri, Santo Raffaele; Nicoletti, Roberto; Maschio, Alessandro Del; Gianolli, Luigi; Fazio, ...
Journal:
International journal of cancer
Issue:
Volume 132:Issue 11(2013:Jun. 01)
Page Start:
2557
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series. (June 2022)

Authors:
Hafliger, Emilie; Boccaccino, Alessandra; Lapeyre-Prost, Alexandra; Perret, Audrey; Gallois, Claire; Antista, Maria; Pilla, Lorenzo; Lecomte, Thierry; Scartozzi, Mario; Soularue, Emilie; Salvatore, Lisa; Bourgeois, Vincent; Salati, Massimiliano; Tougeron, David; Evesque, Ludovic; Vaillant, Jean-N...
Journal:
European journal of cancer
Issue:
Volume 168(2022)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study. (1st February 2016)

Authors:
Maccalli, Cristina; Giannarelli, Diana; Capocefalo, Filippo; Pilla, Lorenzo; Fonsatti, Ester; Di Giacomo, Anna Maria; Parmiani, Giorgio; Maio, Michele
Journal:
Oncoimmunology
Issue:
Volume 5:Number 2(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗